- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Minnesota Health Exchange's CEO Resigning
MNsure's chief executive announced his resignation Monday, paving the way for a third leadership shakeup at the beleaguered agency in less than 2 years.
MNsure's chief executive announced his resignation Monday, paving the way for a third leadership shakeup at the beleaguered agency in less than 2 years.
Scott Leitz will step down later this month after just 18 months on the job to take a position at a Washington, DC-based health policy think tank. MNsure's board of directors accepted his resignation Monday and appointed one of his deputies to lead the agency in the interim.
The leadership shakeup comes as Minnesota lawmakers debate the exchange's future, with proposals ranging from abolishing its governing board and establishing MNsure as a full-blown state agency to dismantling MNsure entirely and shifting to the federally-run exchange. Any planning for a permanent replacement will wait until Republicans and Democrats hammer out a deal to solidify MNsure's future.
Read more StarTribune: http://strib.mn/1Id3GVB
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More
